Emergence of High-Level Daptomycin Resistance in Corynebacterium striatum in Two Patients with Left Ventricular Assist Device Infections
- 1 April 2016
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 22 (3) , 233-237
Abstract
Introduction: We describe the clinical and microbiologic courses of two patients with ventricular assist device infections secondary to Corynebacterium striatum treated with daptomycin. In both cases, the pathogen was initially susceptible to daptomycin (minimum inhibitory concentration [MIC] 256 mg/L) during therapy. Methods: The clonal nature of the isolates was determined by pulse-field gel electrophoresis (PFGE). Daptomycin binding was assessed by fluorescence microscopy using daptomycin–boron-dipyrromethene (bodipy). Induction and stability of daptomycin resistance were assessed by culturing strains in the presence of low concentrations of daptomycin or passage of resistant strains on daptomycin-free medium and repeat MIC testing, respectively. Results: PFGE revealed that resistant clinical isolates were genetically indistinguishable from their parent strains, but the two pairs were unrelated to each other. The resistant strains had 7.5–15 times lower binding of daptomycin-bodipy compared to the related susceptible strains ( p ≤ 0.0002). High-level daptomycin resistance (MIC >256 mg/L) was generated in vitro for both susceptible parent strains after overnight culture in the presence of daptomycin. One of the resistant strains maintained a high-level resistance phenotype up to 5 days of passage on daptomycin-free medium, whereas the other strain reverted back to a susceptible phenotype (MIC = 0.38 mg/L) after one passage on daptomycin-free medium, with a concomitant increase in daptomycin binding. Conclusions: High-level daptomycin resistance in C. striatum was readily generated in vitro and during the course of therapy in these patients. This resistance appears to be mediated by reduced daptomycin binding. Providers should be cautious about using long-term daptomycin monotherapy for C. striatum infections.Keywords
This publication has 13 references indexed in Scilit:
- Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trialsJournal of Antimicrobial Chemotherapy, 2014
- Multidrug-resistant Corynebacterium striatum endocarditis successfully treated with daptomycinInternational Journal of Antimicrobial Agents, 2012
- Native Valve Endocarditis Caused by Corynebacterium striatum with Heterogeneous High-Level Daptomycin Resistance: Collateral Damage from Daptomycin Therapy?Antimicrobial Agents and Chemotherapy, 2012
- Pacemaker Lead Endocarditis Due to Multidrug-Resistant Corynebacterium striatum Detected with Sonication of the DeviceJournal of Clinical Microbiology, 2010
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- First report of prosthetic mitral valve endocarditis due to Corynebacterium striatum: Successful medical treatment. Case report and literature reviewJournal of Infection, 2006
- Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseasesDiagnostic Microbiology and Infectious Disease, 2006
- Successful Treatment of Corynebacterium striatum Endocarditis with Daptomycin plus RifampinAnnals of Pharmacotherapy, 2005
- Corynebacterium striatum: an underappreciated community and nosocomial pathogenJournal of Infection, 2005
- Native Valve Endocarditis Due to Corynebacterium striatum: Case Report and ReviewClinical Infectious Diseases, 1994